Control Bionics Ltd (cbl) Logo

Control Bionics Ltd (CBL)

___:___ · AUD

CBL Chart

CBL's Principal Activity is the technology company that designs, manufactures and sells augmentative and alternative communication technology that allows users to operate and communicate via computer using their thoughts and neural signals.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume (4w avg)
Day Range -
Prev Close
Last Trade


1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -69.63%


Market Capitalisation
ASX Rank 1,529 of 2,295
Sector Rank

Key Information

Shares Issued
Sector Healthcare
Similar Companies -
EPS -$0.025
DPS $0.00
NTA per share $0.19

Broker Consensus

CBL is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.


Date Heading Pages File Size Time

Company Overview

Control Bionics Limited (CBL) designs, manufactures and sells wireless wearable electromyography (EMG) based augmentative and alternative communication (AAC) technology. This allows users to operate and communicate via a computer using intentional thought and the body's own neuroelectric signals detected at skeletal muscle sites - the physical movement of a muscle is not necessary for the technology to detect and interface.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Surrey Hills VIC 3127
Registry Automic Group
Auditor BDO Audit Pty Ltd
Date Listed 7 Dec 2020

Upcoming Calendar (Forecasted)

Date Event
24/02/2022 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
08/09/2017 $0.0135 0% $0.0135 Interim 21/09/2017
13/03/2017 $0.0183 0% $0.0183 Final 31/03/2017
27/10/2016 $0.0283 0% $0.0283 Interim 04/11/2016
14/04/2016 $0.0404 0% $0.0404 Final 22/04/2016

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM) $0.00
Gross DPS(TTM) $0.00
Dividend yield
Gross yield
Payout Ratio --
DRP Features -

Directors & Management

Directors & Management

Name Title Since Bio
Mr Damian Lismore Non-Executive Director Sep 2020 Director Bio icon

Mr Damian Lismore

Non-Executive Director

Mr Lismore has held a number of Directorships and has commercial, international and listed company experience (both ASX and NASDAQ), covering many industries including healthcare and technology. In his executive career, he held CEO, CFO and Company Secretarial roles and continues to act as an advisor to CEOs, boards and business owners. Damian is currently CFO of Scout Bio Inc, a Frazier Healthcare Partners backed company, and a Non-Executive Director of ASX listed LBT Innovations Limited (ASX:LBT).He is also Chairman of Risk Committee of the CBL.

Mr Robert William Wong Chief Executive Officer,Managing Director Sep 2020 Director Bio icon

Mr Robert William Wong

Chief Executive Officer,Managing Director

Mr Wong has over 25 years of experience with multinational businesses in senior management and divisional operational roles. He has management experience in developing and commercialising technology products and services. Rob was appointed as CEO and Managing Director in January 2017. He also held the position of CEO at AIMIA Digital Industry Association of Australia. He is also member of Risk Committee of the CBL.

Mr Roger David Hawke Non-Executive Chairman,Non-Executive Director Sep 2018 Director Bio icon

Mr Roger David Hawke

Non-Executive Chairman,Non-Executive Director

Mr Hawke has over 30 years of experience in the telecommunications and technology space, having recently retired after 8 years as CEO & Managing Director of Crown Castle Australia/Axicom, and has experience particularly in Technology, Operations, Sales and Management. He is a Non-Executive Director of Infrastructure Logic Pty Ltd. He is also member of Risk Committee of the CBL.

Mr Lindsay John Phillips Non-Executive Director Aug 2014 Director Bio icon

Mr Lindsay John Phillips

Non-Executive Director

Mr Phillips has been involved in private equity for over 30 years, commencing in 1987 with M.J.H. Nightingale & Co. Limited in London/New York and subsequently Australia since 1995. His experience includes seven years (1980-87) with Price Waterhouse. Lindsay is currently Chairman of both Nightingale Partners and Phoenix Development Fund and serves as a Director on the majority of the funds' investee companies. Lindsay has been a Non-Executive Director of Control Bionics since August 2014. Lindsay has held a number of listed company board positions. He is currently chairman of Enprise Group Limited listed on NZX and has been a board member since December 2013. He was also previously chairman of Flat Glass Industries Limited from 2003 to 2015. He is also member of Risk Committee of the CBL.

Mr Peter Shann Ford Executive Director Jul 2005 Director Bio icon

Mr Peter Shann Ford

Executive Director

Mr Ford has began consulting to therapists and disability clients in innovative Assistive Technology, including bionics and robotics. After spending three years as a founding programmer at the Veterans Administration Medical Center Rehabilitation R&D Laboratory in Atlanta - one of the first of its kind in the USA - while a news anchor at CNN and CNN2. In 2000, Peter identified that a patients' disabled muscles still emitted small electrical signals that could be used to reliably control basic computer functions. Peter is the Company Founder and has been a Director of the Company since its incorporation in 2005. He is also member of Risk Committee of the CBL.

Mr Brett Thomas Crowley Company Secretary N/A

Director Transactions

CBL directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
18/03/21 Damian Lismore Buy +25,000 $0.61 $15,250 On-market trade

Director Interests

The current holdings of CBL directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Damian Lismore 18/03/2021 N/A 55,000 N/A N/A
Robert Wong 29/09/2020 N/A 2,540,616 3,365,678 N/A
Roger Hawke 19/09/2018 N/A 758,478 N/A N/A
Lindsay Phillips 07/08/2014 N/A 17,195,676 N/A N/A
Peter Ford 26/07/2005 21,258,313 N/A 3,567,860 N/A

Shareholder Info

Top 20 Shareholders About the Data

Data supplied by Morningstar and accurate on Dec 1, 2020.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Peter Shann Ford 21,258,313 25.51%
Nightingale Partners Pty Limited 9,117,123 10.94%
Phoenix Development Fund Limited 8,019,581 9.62%
National Nominees Limited 2,866,668 3.44%
BNP Paribas Noms Pty Ltd (Drp) 2,833,334 3.40%
Loidl Nominees Pty Ltd (Loidl Family A/C) 2,541,289 3.05%
R & R Wong Holdings Pty Limited (R & R Wong Family Super A/C) 2,540,616 3.05%
CS Third Nominees Pty Limited (HSBC Cust Nom Au Ltd 13 A/C) 2,500,000 3.00%
Pacific Atlantic Commerce Pty Ltd (Corcillum Superfund A/C) 1,424,366 1.71%
James Schorey 1,402,366 1.68%
Windward Capital Pty Ltd (S&L Rix Superfund A/C) 1,147,719 1.38%
Dowe Holdings Pty Limited 1,121,893 1.35%
HSBC Custody Nominees (Australia) Limited 1,018,334 1.22%
Santios Pty Limited (The Mcmurray Family A/C) 999,219 1.20%
Washington H Soul Pattinson And Company Limited 833,334 1.00%
Nandaroo Pty Ltd 792,202 0.95%
Robert Allwell Pty Ltd (Robert Allwell Superfund A/C) 781,757 0.94%
Paula Darling 781,757 0.94%
Hafnium Management Pty Ltd (Hafnium Family A/C) 758,478 0.91%
Paul Mahon 701,183 0.84%
Blacs Investment Group Pty Ltd (Blacs Two A/C) 670,987 0.81%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 0 441 530 376 40 1,387

Substantial Shareholders

No Substantial Shareholders for CBL in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
05-03-21 Acorn Capital Limited 4,422,182 -- 5.27
07-12-20 Peter Shann Ford 21,258,313 -- 25.51
07-12-20 Phoenix Development Fund Limited 8,019,581 -- 9.62
07-12-20 Nightingale Partners Pty Limited 9,117,123 -- 10.94

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
Page Icon
CBL Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.